| 000 | 00919 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250514163147.0 | ||
| 264 | 0 | _c20040917 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a1470-269X | ||
| 024 | 7 |
_a10.1038/sj.tpj.6500219 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeijer, C | |
| 245 | 0 | 0 |
_aProtecting communities in pharmacogenetic and pharmacogenomic research. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _c2004 |
||
| 300 |
_a9-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInformed Consent _xethics |
| 650 | 0 | 4 |
_aPharmacogenetics _xeconomics |
| 650 | 0 | 4 | _aResidence Characteristics |
| 700 | 1 | _aMiller, P B | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 4 _gno. 1 _gp. 9-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.tpj.6500219 _zAvailable from publisher's website |
| 999 |
_c14381917 _d14381917 |
||